Company Announcements

Replacement - Director/PDMR Shareholding

Source: RNS
RNS Number : 6819H
Aviva PLC
21 March 2024
 

                                                        

 

News Release

 

21 March 2024

 

Aviva plc

 

Amendment

 

The following amendments have been made to the 'Director/PDMR Shareholding' announcement released on 15 March 2024 at 11:17 under RNS number 0699H:

 

1.         The aggregate prices have corrected as follows:

 

•           Mark Versey - £245.31 from £218.63

•           Douglas Brown - £250.12 from £222.92

•           James Hillman - £250.12 from £222.92

 

2.         The date of James Hillman's transaction is corrected to 2024-15-03 from 2024-16-02.

 

All other details remain unchanged. The full amended text is shown below.

 

Notification of Transactions of Directors and Persons Discharging Managerial Responsibilities (PDMRs)

 

Aviva announces that the share interests of the following PDMRs have increased following the monthly acquisition of shares under the Aviva Matching Share Plan. The transactions were made in London on 15 March 2024.

 

Name

Share Price

No. of shares

Mark Versey

£4.809906

51

Douglas Brown

£4.809906

52

James Hillman

£4.809906

52

 

 

This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mark Versey

2

Reason for the notification

a)

Position/status

CEO of Aviva Investors

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aviva plc

b)

LEI

YF0Y5B0IB8SM0ZFG9G81

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares

 

GB00BPQY8M80

b)

Nature of transaction

Monthly purchase of shares under the Aviva Matching Share Plan, a HMRC approved share incentive plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£4.809906

51

d)

Aggregated information

- Aggregated volume

- Price

 

51

£245.31

e)

Date of the transaction

2024-03-15

f)

Place of the transaction

London Stock Exchange, XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Douglas Brown

2

Reason for the notification

a)

Position/status

CEO of Insurance, Wealth & Retirement

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aviva plc

b)

LEI

YF0Y5B0IB8SM0ZFG9G81

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares

 

GB00BPQY8M80

b)

Nature of transaction

Monthly purchase of shares under the Aviva Matching Share Plan, a HMRC approved share incentive plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£4.809906

52

d)

Aggregated information

- Aggregated volume

- Price

 

52

£250.12

e)

Date of the transaction

2024-03-15

f)

Place of the transaction

London Stock Exchange, XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

James Hillman

2

Reason for the notification

a)

Position/status

Group Chief Risk Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aviva plc

b)

LEI

YF0Y5B0IB8SM0ZFG9G81

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares

 

GB00BPQY8M80

b)

Nature of transaction

Monthly purchase of shares under the Aviva Matching Share Plan, an HMRC approved share incentive plan.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£4.809906

52

d)

Aggregated information

- Aggregated volume

- Price

 

52

£250.12

e)

Date of the transaction

2024-03-15

f)

Place of the transaction

London Stock Exchange, XLON

 

 

-ends-

 

 

Enquiries:

 

Media:

 

Andrew Reid                                                                           +44 (0)7800 694 276

Sarah Swailes                                                                           +44 (0)7800 694 859

Marion Fischer                                                                         +44 (0)7800 693 219

 

Analysts:                                                                                                

 

Rupert Taylor Rea                                                                   +44 (0)7385 494 440

Joel von Sternberg                                                                   +44 (0)7384 231 238

Michael O'Hara                                                                        +44 (0)7387 234 388

 

Notes to editors:

·    We are the UK's leading diversified insurer and we operate in the UK, Ireland and Canada. We also have international investments in India and China.

·    We help our 19.2 million customers make the most out of life, plan for the future, and have the confidence that if things go wrong we'll be there to put it right.

·    We have been taking care of people for more than 325 years, in line with our purpose of being 'with you today, for a better tomorrow'. In 2023, we paid £25.6 billion in claims and benefits to our customers.

·    In 2021, we announced our ambition to become Net Zero by 2040, the first major insurance company in the world to do so. We are aiming to have Net Zero carbon emissions from Aviva's operations and supply chain by 2030. While we are working towards our sustainability ambitions, we recognise that while we have control over Aviva's operations and influence on our supply chain, when it comes to decarbonising the economy in which we operate and invest, Aviva is one part of a far larger global ecosystem. There are also limits to our ability to influence other organisations and governments. Nevertheless, we remain focused on the task and are committed to playing our part in the collective effort to enable the global transition. Find out more about our climate goals at www.aviva.com/climate-goals  and our sustainability ambition and action at www.aviva.com/sustainability

·    Aviva is a Living Wage, Living Pension and Living Hours employer and provides market-leading benefits for our people, including flexible working, paid carers leave and equal parental leave. Find out more at www.aviva.com/about-us/our-people

·    As at 31 December 2023, total Group assets under management at Aviva Group were £376 billion and our estimated Solvency II shareholder capital surplus was £8.8 billion. Our shares are listed on the London Stock Exchange and we are a member of the FTSE 100 index.

·    For more details on what we do, our business and how we help our customers, visit www.aviva.com/about-us  

·    The Aviva newsroom at www.aviva.com/newsroom includes links to our spokespeople images, podcasts, research reports and our news release archive. Sign up to get the latest news from Aviva by email.

·    You can follow us on:

X: www.x.com/avivaplc

LinkedIn: www.linkedin.com/company/aviva-plc 

Instagram: www.instagram.com/avivaplc

·    For the latest corporate films from around our business, subscribe to our YouTube channel: www.youtube.com/user/aviva 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAXDEALDLEFA